checkAd

    Human Milk Oligosaccharides Market Worth USD 170.4 Million by 2024  334  0 Kommentare Hexa Research - Seite 2

    Some of the key manufacturers in the Human Milk Oligosaccharides (HMO) market include Inbiose; Jennewein Biotechnologie GmbH; Elicityl SA; Glycom A/S; ZuChem, Inc.; Medolac Laboratories; and Glycosyn LLC. Increased number of health claims in U.S. and several developed markets of Europe has spurred studies to explore the potential of HMO. These studies have derived different microbial challenges in gut, prevention of diarrhea, and protection from infectious diseases. In September 2013, ZuChem launched new HMO formulations including l-galactose, as well as sugar phosphates such as β-l-glucose-1-phosphate, α-d-galactose-1-phosphate, and β-l-xylose-1-phosphate. In October 2014, U.S. based Madolac Laboratories completed construction of second phase of HMO purification plant. This plant will synthesize human milk oligosaccharides on a large scale, which will be further used in clinical trials and scientific research.

    Browse related reports by Hexa Research: 

    • Lactoferrin Market - Global lactoferrin market size was valued at USD 87.8 million in 2017 and is expected to witness further growth over the forecast period. Rising demand for infant formula as a result of high birth rate in emerging economies like China and India is expected to remain a principal driving force for the market.
    • Botanical Supplements Market - Global botanical supplements market size was valued at USD 17.74 billion in 2017 and is expected to register a CAGR of over 9% over the forecast period. Rising concerns regarding the adverse effects of synthetically derived nutraceuticals are projected to augment the demand for botanical supplements.
    • Prebiotics Market - Global prebiotics market size was valued at USD 3.34 billion in 2016 and is anticipated to expand at a CAGR of 10.0% over the forecast period. Increasing use of prebiotics in several dairy products is projected to augment the market expansion.
    • Probiotics Ingredients Market - Global probiotics ingredients market size was valued at USD 1.95 billion in 2017 and is expected to grow further over the forecast period. Rising preference towards preventive healthcare coupled with awareness regarding the inherent benefits of fiber ingredients is expected to boost the overall market.

    Hexa Research has segmented the global human milk oligosaccharides (HMO) market report based on application and region: 

    Seite 2 von 3



    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Human Milk Oligosaccharides Market Worth USD 170.4 Million by 2024 Hexa Research - Seite 2 FELTON, California, October 4, 2018 /PRNewswire/ - The global human milk oligosaccharides (HMO) market size is expected to reach USD 170.4 million by 2024. It is anticipated to expand at a CAGR of 12.3% over the forecast period. HMO is a bioactive …

    Schreibe Deinen Kommentar

    Disclaimer